These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11368764)

  • 1. The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association.
    James MF; Manchanda N; Gonzalez-Agosti C; Hartwig JH; Ramesh V
    Biochem J; 2001 Jun; 356(Pt 2):377-86. PubMed ID: 11368764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
    Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
    J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
    Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
    J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
    Laulajainen M; Muranen T; Carpén O; Grönholm M
    Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Merlin differentially associates with the microtubule and actin cytoskeleton.
    Xu HM; Gutmann DH
    J Neurosci Res; 1998 Feb; 51(3):403-15. PubMed ID: 9486775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
    Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
    BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.
    Maeda M; Matsui T; Imamura M; Tsukita S; Tsukita S
    Oncogene; 1999 Aug; 18(34):4788-97. PubMed ID: 10490812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP.
    Nguyen R; Reczek D; Bretscher A
    J Biol Chem; 2001 Mar; 276(10):7621-9. PubMed ID: 11106646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumour suppressor protein NF2/merlin: the puzzle continues.
    Hovens CM; Kaye AH
    J Clin Neurosci; 2001 Jan; 8(1):4-7. PubMed ID: 11148074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Merlin differs from moesin in binding to F-actin and in its intra- and intermolecular interactions.
    Huang L; Ichimaru E; Pestonjamasp K; Cui X; Nakamura H; Lo GY; Lin FI; Luna EJ; Furthmayr H
    Biochem Biophys Res Commun; 1998 Jul; 248(3):548-53. PubMed ID: 9703963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
    Wiederhold T; Lee MF; James M; Neujahr R; Smith N; Murthy A; Hartwig J; Gusella JF; Ramesh V
    Oncogene; 2004 Nov; 23(54):8815-25. PubMed ID: 15467741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF.
    Gonzalez-Agosti C; Wiederhold T; Herndon ME; Gusella J; Ramesh V
    J Biol Chem; 1999 Nov; 274(48):34438-42. PubMed ID: 10567424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NF2 tumor suppressor Merlin and the ERM proteins interact with N-WASP and regulate its actin polymerization function.
    Manchanda N; Lyubimova A; Ho HY; James MF; Gusella JF; Ramesh N; Snapper SB; Ramesh V
    J Biol Chem; 2005 Apr; 280(13):12517-22. PubMed ID: 15699051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The merlin tumor suppressor localizes preferentially in membrane ruffles.
    Gonzalez-Agosti C; Xu L; Pinney D; Beauchamp R; Hobbs W; Gusella J; Ramesh V
    Oncogene; 1996 Sep; 13(6):1239-47. PubMed ID: 8808698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells.
    Lallemand D; Saint-Amaux AL; Giovannini M
    J Cell Sci; 2009 Nov; 122(Pt 22):4141-9. PubMed ID: 19910496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.
    Bashour AM; Meng JJ; Ip W; MacCollin M; Ratner N
    Mol Cell Biol; 2002 Feb; 22(4):1150-7. PubMed ID: 11809806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of the merlin-I product of the neurofibromatosis type 2 tumour suppressor gene to a novel site in beta-fodrin is regulated by association between merlin domains.
    Neill GW; Crompton MR
    Biochem J; 2001 Sep; 358(Pt 3):727-35. PubMed ID: 11535133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading.
    Gutmann DH; Sherman L; Seftor L; Haipek C; Hoang Lu K; Hendrix M
    Hum Mol Genet; 1999 Feb; 8(2):267-75. PubMed ID: 9931334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The merlin interacting proteins reveal multiple targets for NF2 therapy.
    Scoles DR
    Biochim Biophys Acta; 2008 Jan; 1785(1):32-54. PubMed ID: 17980164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton.
    Sainio M; Zhao F; Heiska L; Turunen O; den Bakker M; Zwarthoff E; Lutchman M; Rouleau GA; Jääskeläinen J; Vaheri A; Carpén O
    J Cell Sci; 1997 Sep; 110 ( Pt 18)():2249-60. PubMed ID: 9378774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.